These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 8680807

  • 1. Effects of monoisoamyl meso-2,3-dimercaptosuccinate on arsenite-induced maternal and developmental toxicity in mice.
    Domingo JL, Gómez M, Sánchez DJ, Llobet JM, Jones MM, Singh PK.
    Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):389-400. PubMed ID: 8680807
    [Abstract] [Full Text] [Related]

  • 2. Assessment of the protective activity of monisoamyl meso-2,3-dimercaptosuccinate against methylmercury-induced maternal and embryo/fetal toxicity in mice.
    Bellés M, Sánchez DJ, Gómez M, Domingo JL, Jones MM, Singh PK.
    Toxicology; 1996 Jan 08; 106(1-3):93-7. PubMed ID: 8571406
    [Abstract] [Full Text] [Related]

  • 3. Developmental toxicity evaluation of monoisoamyl meso-2,3-dimercaptosuccinate in mice.
    Bosque MA, Domingo JL, Corbella J, Jones MM, Singh PK.
    J Toxicol Environ Health; 1994 Aug 08; 42(4):443-50. PubMed ID: 8051718
    [Abstract] [Full Text] [Related]

  • 4. meso-2,3-Dimercaptosuccinic acid and prevention of arsenite embryotoxicity and teratogenicity in the mouse.
    Domingo JL, Bosque MA, Piera V.
    Fundam Appl Toxicol; 1991 Aug 08; 17(2):314-20. PubMed ID: 1662650
    [Abstract] [Full Text] [Related]

  • 5. Effect of monoisoamyl meso-2,3-dimercaptosuccinate on the pathology of acute cadmium intoxication.
    Xu C, Holscher MA, Jones MM, Singh PK.
    J Toxicol Environ Health; 1995 Jul 08; 45(3):261-77. PubMed ID: 7609002
    [Abstract] [Full Text] [Related]

  • 6. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
    Kostial K, Kargacin B, Blanusa M, Piasek M, Jones MM, Singh PK.
    Environ Health Perspect; 1994 Sep 08; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123
    [Abstract] [Full Text] [Related]

  • 7. Reduction of lead retention by mono-3-methylbutan-1-yl meso-2,3-dimercaptosuccinate in suckling rats.
    Blanusa M, Kostial K, Piasek M, Jones MM, Singh PK.
    Analyst; 1995 Mar 08; 120(3):951-3. PubMed ID: 7741262
    [Abstract] [Full Text] [Related]

  • 8. Antidotal efficacy of newly synthesized dimercaptosuccinic acid (DMSA) monoesters in experimental arsenic poisoning in mice.
    Kreppel H, Reichl FX, Kleine A, Szinicz L, Singh PK, Jones MM.
    Fundam Appl Toxicol; 1995 Jul 08; 26(2):239-45. PubMed ID: 7589912
    [Abstract] [Full Text] [Related]

  • 9. Amelioration by BAL (2,3-dimercapto-1-propanol) and DMPS (sodium 2,3-dimercapto-1-propanesulfonic acid) of arsenite developmental toxicity in mice.
    Domingo JL, Bosque MA, Llobet JM, Corbella J.
    Ecotoxicol Environ Saf; 1992 Jun 08; 23(3):274-81. PubMed ID: 1376232
    [Abstract] [Full Text] [Related]

  • 10. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats.
    Kostial K, Blanusa M, Piasek M, Jones MM, Singh PK.
    Pharmacol Toxicol; 1995 Sep 08; 77(3):216-8. PubMed ID: 8884886
    [Abstract] [Full Text] [Related]

  • 11. Mobilization of lead in mice by administration of monoalkyl esters of meso-2,3-dimercaptosuccinic acid.
    Walker EM, Stone A, Milligan LB, Gale GR, Atkins LM, Smith AB, Jones MM, Singh PK, Basinger MA.
    Toxicology; 1992 Nov 22; 76(1):79-87. PubMed ID: 1335621
    [Abstract] [Full Text] [Related]

  • 12. Monoisoamyl dimercaptosuccinic acid induced changes in pregnant female rats during late gestation and lactation.
    Mehta A, Pant SC, Flora SJ.
    Reprod Toxicol; 2006 Jan 22; 21(1):94-103. PubMed ID: 16040228
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats.
    Kostial K, Blanusa M, Piasek M, Simonović I, Jones MM, Singh PK.
    Arh Hig Rada Toksikol; 1993 Sep 22; 44(3):217-22. PubMed ID: 8311694
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Developmental toxicity of subcutaneously administered meso-2,3-dimercaptosuccinic acid in mice.
    Domingo JL, Paternain JL, Llobet JM, Corbella J.
    Fundam Appl Toxicol; 1988 Nov 22; 11(4):715-22. PubMed ID: 2852612
    [Abstract] [Full Text] [Related]

  • 18. Effects of combined administration of captopril and DMSA on arsenite induced oxidative stress and blood and tissue arsenic concentration in rats.
    Kalia K, Narula GD, Kannan GM, Flora SJ.
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Jan 22; 144(4):372-9. PubMed ID: 17188940
    [Abstract] [Full Text] [Related]

  • 19. Design of in vivo cadmium-mobilizing agents: synthesis and properties of monobenzyl meso-2,3-dimercaptosuccinate.
    Jones MM, Singh PK, Basinger MA, Gale GR, Smith AB, Harris WR.
    Chem Res Toxicol; 1994 Jan 22; 7(3):367-73. PubMed ID: 8075368
    [Abstract] [Full Text] [Related]

  • 20. Meso-2,3-dimercaptosuccinic acid (DMSA) affects maternal and fetal copper metabolism in Swiss mice.
    Taubeneck MW, Domingo JL, Llobet JM, Keen CL.
    Toxicology; 1992 Jan 22; 72(1):27-40. PubMed ID: 1311466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.